# Avista Pharma Solutions, Inc. dba Cambrex – FDA Inspection, May 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/d49d28da-b239-4a0c-8f51-8a56a673d5d4
Source feed: FDA_Inspections

> FDA inspection 1237587 of Avista Pharma Solutions, Inc. dba Cambrex, May 03, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237587
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2024-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1072967 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/351ce4fd-8083-4249-973f-dd508cc0bde1)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cecilia-h-kieu/3ba5feb0-d49e-4301-ae5c-b84bd604a159)
- [Issuing Officer](https://www.keypedia.com/people/michael-s-budziak/23634aff-ee10-4f94-a4c1-2cf9dd4922bc)
- [Miguel A. Martinez](https://www.keypedia.com/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)
- [FDA Associated Person](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)

Company: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/ca9e4205-cd7f-44bd-8dbe-a9d98be57047

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
